期刊文献+

Rho激酶抑制剂Y-27632对胶质瘤细胞生长与迁移能力的影响 被引量:1

Effect of Y-27632 Rho-kinase Inhibitor on Proliferation and Migration of Human Glioblastoma Cell
下载PDF
导出
摘要 目的观察Rho激酶(ROCKS)特异性抑制剂Y-27632对体外培养的U87胶质瘤细胞迁移能力的影响。方法体外培养U87胶质瘤细胞,采用MTT实验、Transwell体外细胞迁移实验,检测Rho激酶抑制剂Y-27632对人U87胶质瘤细胞生长和迁移能力的影响。Rho激酶检测试剂盒检测Y-27632对ROCKS活性的抑制率。结果 Y-27632对U87细胞生长活性无明显影响;细胞迁移能力明显下降,与对照组相比差异性显著,统计学处理P<0.05。随着Y-27632浓度的增加,细胞中ROCKS活性逐渐抑制,呈浓度依赖性。结论 Rho激酶抑制剂Y-27632能明显抑制U87胶质瘤细胞的体外迁移能力。 Objective To explore the effects of Y-27632,inhibitor of Rho-kinase on proliferation and migration of U87 glioblastoma cells in vitro. Methods U87 cells were treated with Y-27632 of different concentrations in vitro,cell proliferation inhibition was detected by MTT colorimetric assay;cell migration inhibition was detected by cell motility assay.Inhibition of Rho-kinase was detected by Rho-kinase Assay Kit. Results The activity of U87 glioblastoma cell was not disturbed.Cell migration was suppressed strongly.Y-27632 could decrease the activity of Rho-kinase with dose-dependence. Conclusion Y-27632,inhibitor of Rho-kinase could significantly inhibit the migration of U87 glioblastoma cell in vitro.
出处 《河南科技大学学报(医学版)》 2010年第4期247-249,252,共4页 Journal of Henan University of Science & Technology:Medical Science
关键词 RHO激酶 U87细胞 细胞迁移 Rho-kinase U87 Glioblastoma Cell Cell Migration
  • 相关文献

参考文献10

  • 1李玉林.病理学[M].第6版.北京:人民卫生出版社,2003:210.
  • 2Mueller BK,Mack H,Teusch N.Rho kinase,a promising drug target for neurological disorders[J].Nat Rev Drug Discov,2005,4:387-398.
  • 3Hammerschlag R,et al.Axonal transport and the neuronal cytoskeleton.Basic Neuro-Chemistry:molecular,cellular,and medical aspects[J].1989,4:457-477.
  • 4Matozaki T,Nakanishi H,Takai Y.Small G-protein networks:their crosstalk and signal cascades[J].Cell Signal,2000,12(8):515-524.
  • 5Kjoller L,Hall A.Signaling to Rho GTPases[J].Exp Cell Res,1999,253 (1):166-179.
  • 6Nakagawa O.ROCK-I and ROCK-II,two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice[J].FEBS Lett,1996,392:189-93.
  • 7Oellers P,Schr?er U,Senner V,et al.ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons[J].GLIA 2009,57:499-509.
  • 8Ishizaki T,UehataM,Tamechika I,et al.Pharmacological properties of Y-27632,a specific inhibitor of Rho-associated kinases[J].M ol Pharm acol,2000,57 (5):976-983.
  • 9Ogawa T,Tashiro H,Miyata Y,et al Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model[J].American Journal of Transplantation,2007,7(2):347.
  • 10Budzyn K,Marley PD,Sobey CG.Targeting Rho and Rho-kinase in the treatment of cardiovascular disease[J].Trends Pharm acol Sci,2006,27 (2):97-104.

共引文献8

同被引文献6

  • 1蒋传路,江涛,李永利,Sonny Song.胶质瘤的侵袭性生长与手术策略[J].中华神经外科杂志,2004,20(6):510-512. 被引量:26
  • 2Eleni Makrodouli,Eftychia Oikonomou,Michal Koc,et al.BR AF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells:a comparative study[J].Mol Cancer,2011,10:118.
  • 3Oellers P,Schr er U,Senner V,et al.ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons[J].GLIA,2009,57:499-509.
  • 4akayama M,Amano M,Katsumi A,et al.Rho-kinase and myosinⅡactivities are required for cell type and environment specific migration[J].Cenes Cells,2005,10:107-117.
  • 5Ishizaki T,UehataM,Tamechika I,et al.Pharmacological properties of Y-27632,a specific inhibitor of Rho-associated kinases[J].Mol Pharmacol,2000,57(5):976-983.
  • 6Huang XN,Fu J,Wang WZ.The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis[J].J Neuroimmunol,2011,239(1-2):61-617.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部